Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 628 Stomach Neoplasms 76 Neoplasm Metastasis 59 Neoplasms 39 HER2-positive Breast Cancer 33 Breast Neoplasms, Male 30 Colorectal Neoplasms 28 Brain Neoplasms 25 Carcinoma, Non-Small-Cell Lung 21 Inflammatory Breast Neoplasms 20 Esophageal Neoplasms 20 Pancreatic Neoplasms 13 Triple Negative Breast Neoplasms 12 Lung Neoplasms 11 Endometrial Neoplasms 11 Ovarian Neoplasms 10 Colonic Neoplasms 10 Urinary Bladder Neoplasms 9 Rectal Neoplasms 9 Prostatic Neoplasms 9 Cardiotoxicity 8 Adenocarcinoma 8 Salivary Gland Neoplasms 7 Gallbladder Neoplasms 7 Breast Diseases 7 Biliary Tract Neoplasms 7 Adenocarcinoma Of Esophagus 7 Uterine Cervical Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 6 Sarcoma 6

Interventions

pegylated granulocyte colony-stimulating factor 1 Trastuzumab 1 Omacor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breastcancer × Trastuzumab × Clear all

NCT03014076 2017-01-09

Immunotherapy Vaccine and Herceptin in Breast Cancer

Cancer Insight, LLC

Phase 1 Completed

Breastcancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡